NASDAQ NMS - GLOBAL MARKET · GUTS
+7.68% · +$0.0599 · Vol Not reported
Pre-market · updated 04:53:57 ET
Fractyl Health Inc

Fractyl Health Inc

Health Care
$0.8399
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
GUTS
Fractyl Health Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

46/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GUTS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GUTS catalysts
About Fractyl Health Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2024
Employees
73
Country
US

Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.7800
Last session
Day high
$0.7800
Last session
Day low
$0.7800
Last session
Previous close
$0.7800
52W high
$2.37
-64.56% from high
52W low
$0.3927
23% of range
Market cap
$124.2M
EPS
$-1.3800
Beta
2.22
Shares out
159.2M
Avg volume
1.8M
VWAP
$0.7800
Last session
Price history computed in-house
1W
+27.26%
1M
+8.65%
3M
-8.49%
1Y
-17.66%
YTD
-61.82%
SMA 50 $0.7589 · above
SMA 200 $0.9921 · below
52W position 23%

GUTS overview

Veridion Score
46
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GUTS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GUTS Form 4 filings
Public disclosures

Congress activity in GUTS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for GUTS in the cached public ledger.

Federal contracts

GUTS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GUTS in this window.
Lobbying spend

GUTS lobbying filings, year to date.

Registered lobbying filings matched to Fractyl Health Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GUTS in this window.
Loading news for GUTS
Analyst ratings
Sovereign unlock shows live analyst consensus for GUTS.
Options
Sovereign unlock shows live options positioning for GUTS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.